Evangelista, Athena Emiethyst Y.

HRN: 16-11-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
OXACILLIN 500MG (VIAL)
08/15/2023
08/15/2023
IV
500mg
Ptor
For Or Prophylaxis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: